The indication is indeed a claim. But it is sufficiently "balanced" with lowest level fair balance general statement (i.e. complete indication with the statement to consult the PM for contraindications, warnings...). The piece you've described is not exempt. Per the document cited in your question, product advertising is only exempt there are absolutely no messages other than drug name +/- claims explicitly listed in the PAAB code s6.6.
